about
Pathogenesis and potential therapeutic targets in systemic lupus erythematosus: from bench to bedsideLupus clinical development: will belimumab's approval catalyse a new paradigm for SLE drug development?New age of biological therapies in paediatric rheumatology.Rituximab and lupus--a promising pair?Republished: new age of biological therapies in paediatric rheumatology.Lupus nephritis: an update.Pharmacological Management of Childhood-Onset Systemic Lupus Erythematosus.Beyond pan-B-cell-directed therapy - new avenues and insights into the pathogenesis of SLE.
P2860
Q35309470-ABA43D13-07E4-455E-87E7-610032F73248Q38184585-E10F5521-A1F6-46CC-B31C-01426CC3F6F3Q38195363-93CCE2E5-B4FA-4EF6-83A5-7D2E90A0E7E7Q38235185-29A5113C-D248-4E9F-BBBE-75631567F10DQ38250593-E1457679-44DE-4313-900C-37C419E38A58Q38608138-65E2AB97-6C87-4BBD-BF16-2A39EF81C692Q38771936-447F7A58-929D-4C8F-8AC7-BB044917D0D0Q38979169-F1C88B0E-9D34-4740-B3B6-5F31C3397016
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Biologics in SLE: towards new approaches.
@en
type
label
Biologics in SLE: towards new approaches.
@en
prefLabel
Biologics in SLE: towards new approaches.
@en
P1476
Biologics in SLE: towards new approaches
@en
P2093
Ronald F van Vollenhoven
P304
P356
10.1016/J.BERH.2013.07.006
P577
2013-06-01T00:00:00Z